1
EXHIBIT 10.7
THIS CONSULTANCY CONTRACT is made on the 1 day of December, 1997
BETWEEN
(1) deCODE genetics, Inc., a Delaware
Corporation with its principal place of business at
Xxxxxxxx, 0
000 Xxxxxxxxx
Xxxxxxx ("Company")
(2) Vane Associates, a partnership,
"White Angles"
0 Xxxxx Xxxx
Xxxxxx Xxxx
Xxxxxx
Xxxx XX0 0XX
Great Britain ("Consultant")
IT IS AGREED:
ENGAGEMENT OF SERVICES
Consultant shall procure that Professor Xxx Xxxx Xxxx ("Xxx Xxxx Xxxx")
acts as directors and will serve as a member of the Company's Board of
Directors (the "Board") and perform the duties of a director, in
accordance with the Company's Amended and Restated Articles of
Incorporation, Bylaws, and the general Corporation Law of Delaware (the
"Services"). The Services will take place from time to time as
reasonably requested by the Company at times mutually acceptable to
Consultant and the Company at meetings in either Reykjavik or,
occasionally, in Boston, Massachusetts and by reviewing and, if thought
fit, executing written consents that may be submitted to members of the
Board from time to time. Xxx Xxxx Xxxx may participate in such meetings
by teleconference. It is anticipated that the Board will meet
approximately five times per year and have approximately five written
consents to review and sign, if thought fit, and that Sir John's time
commitment per year to the Company shall not materially exceed that
number of days.
2
2. COMMENCEMENT
This Agreement shall be deemed to commence with effect from 27 October
1997 and shall continue until the close of business on the third
anniversary of the date of this Agreement and thereafter until
terminated by either party upon 90 days written notice to the other.
3. COMPENSATION
3.1 In consideration of the Consultant's Services and subject to approval
by the Company's Board of Directors, which shall pay to Vane Associates
$2,000 per day for each Board Meeting that Xxx Xxxx Xxxx attends and
shall issue (being each 12 monthly period this Agreement subsists) each
year at monthly intervals to Vane Associates nonstatutory stock options
(the "Options") to purchase up to 15,000 shares of common stock of the
Company in each year at a price equal to its fair market value on the
date of grant pursuant to the terms of the Company's 1996 Equity
Incentive Plan for each of the next four years, provided that Xxx Xxxx
Xxxx continues to serve as a director of the Company at the time the
Options are to be issued. The Options will vest monthly during each
year or part year of this Agreement.
3.2 The Company will also reimburse Vane Associates for reasonable travel
lodging food and other incidental expenses incurred by Consultant in
performing the Services under this Agreement (including travelling to
and from Board Meetings). Consultant agrees to provide the Company with
appropriate receipts or other relevant documentation for all such costs
as part of any submission for reimbursement.
4. FEES
4.1 The Consultant will be entitled to receive the fee referred to above
per meeting or teleconference or agreed day's services of the Company
attended by Xxx Xxxx Xxxx payable to its account at
Midland Bank Plc
00 Xxxxxxx
Xxxxxx XX0X 0XX, Xxxxx Xxxxxxx
Sort Code: 40-03-28
Account No: 00000000
payable in full without deduction for bank transfer changes within 28
days of each meeting;
3
5. EXPENSES
5.1 Company will reimburse the Consultant's first class travel and
out-of-pocket disbursements on behalf of Xxx Xxxx Xxxx for travel,
accommodation and incidental expenses made on behalf of or for the
benefit of Company including travelling to and from Company meetings
which shall be billed to Company at cost as incurred and shall be
supported by appropriate receipts and other relevant documentation.
5.2 Company agrees to reimburse the Consultant all its legal expenses in
reviewing, negotiating and amending this Agreement and the associated
Indemnity Agreement.
6. COPYRIGHT
6.1 All copyrights and/or design rights in any work created in the course
of or under this Agreement shall belong to Company save for papers the
Consultant and/or Xxx Xxxx Xxxx publishes and lectures or delivers
where the copyright and right to copyright become a moral right and a
right to use, deliver and exploit which shall belong to the Consultant
and /or Xxx Xxxx Xxxx.
6.2 For the avoidance of doubt Company, acquires no rights to any
copyright, design rights, moral right, patents or similar intellectual
property rights arising in the course of the Consultant's or Xxx Xxxx
Xxxx'x work under any other consultancies or appointments held from
time to time.
6.3 Sir Xxxx Xxxxx and consultant shall execute Non-Disclosure Agreements
in favour of Company in the form attached hereto as Exhibit A.
7. ACKNOWLEDGEMENT AND ASSIGNMENT
7.1 It is agreed that this Agreement shall enure for the benefit of and be
enforceable by the Consultant and its successors in title.
7.2 This Agreement is not assignable by either party without the prior
written approval of the other.
8. AMENDMENTS
Changes, amendments and supplements to this Agreement must be made in
writing and signed by the parties.
9. GOVERNING LAW
9.1 This Agreement shall be governed by the laws of England.
4
9.2 By their execution of this agreement, the parties hereby irrevocably
agree to submit to the exclusive jurisdiction of the English Courts.
10. TERMINATION
10.1 This Agreement may be terminated by either party without liability to
the other on 90 days written notice to expire no earlier than the close
of business on the third anniversary of this Agreement.
10.2 If either party is in breach of any provision of this Agreement, the
non-breaching party may in writing give the allegedly breaching party
written notice to cure or remedy such breach within 28 days of receipt
of such written notice. If the allegedly breaching party has not cured
or remedied the alleged breach within that period, then this Agreement
may be terminated forthwith upon further written notice.
10.3 The Company shall ensure that the Consultant is reimbursed for the
consultants fees and expenses down to the date of termination howsoever
arising without set-off or deduction.
11. PRE-EXISTING AGREEMENTS
This Agreement is subject to the understanding that the consultant
and/or Xxx Xxxx Xxxx are contracted to and affiliated with various
organizations and other companies and may from time to time become
contracted to and affiliated with other similar organizations and other
companies, including but without limitation on an equity investment
basis (collectively, the "Affiliated Entities"). It is particularly
understood that the Consultant and/or Xxx Xxxx Xxxx are required to
fulfil certain obligations to the Affiliated Entities pursuant to the
guidelines or the policies if any, adopted by the Affiliated Entities
or pursuant to a contract entered into with such Affiliated Entities.
12. INDEMNITY AGREEMENT
In connection with this Agreement, Xxx Xxxx Xxxx and the Company have
executed that certain Indemnity Agreement, dated as 1997.
13. NOTICES
Any notice required or permitted to be given under this Agreement shall
be in writing and shall be deemed effectively served upon personal
delivery or upon delivery by courier or 7 days after posting by
certified mail if sent from the USA or by registered post if sent from
England, in either case sent by express pre-paid air, addressed to the
other party at its address as shown above or to such other address as
such party may designate in writing for the purpose of this Agreement
from time to time.
5
/s/ Xxxx Xxxxxxxxxx /s/ Xxx Xxxx Xxxx
--------------------- ---------------------
Company Consultant
6
DECODE GENETICS, INC.
(A DELAWARE CORPORATION)
NONDISCLOSURE AGREEMENT FOR MEMBERS OF THE BOARD OF DIRECTORS
In connection with your review of certain confidential information of
DECODE GENETICS, INC. (the "Company") as a member of the Company's Board of
Directors, we ask that you read and accept the following conditions concerning
the Company's disclosure of such information to you:
"Proprietary Information" shall mean all information obtained by you
from or disclosed to you by the Company (I) which relates to the Company's past,
present or future research, development or business activities or the results
of such activities or (ii) which the Company has received from others and is
obligated to treat as confidential or proprietary. Proprietary Information shall
not include information previously known to you or publicly disclosed without
breach of an obligation of confidentiality, either prior or subsequent to your
receipt of such information. You agree that you shall hold all Proprietary
Information in confidence and shall not use any Proprietary Information except
as may be authorized by the Company in writing. You shall not disclose any such
Proprietary Information to any person by publication or otherwise. You further
agree that at any time upon request of the Company, you shall return to the
Company any and all written or descriptive matter including, but not limited to,
financial information, descriptions or other papers or documents that contain
any such Proprietary Information, together with all copies thereof. You
acknowledge the receipt of consideration.
If the foregoing reflects your understanding, please sign this
Agreement in the space provided below.
Accepted and Agreed to:
1 December 1997 /s/ Xxxx Xxxx
------------------------------
[Date] [Signature]
Xxx Xxxx Xxxx
------------------------------
[Print Name]
Xxxxx Xxxxxx 0 Xxxxx Xxxx
------------------------------
Xxxxxx Xxxx XX
------------------------------
[Address]
7
AMENDMENT TO CONSULTANCY CONTRACT
This Amendment to Consultancy Contract (this "Amendment") is entered
into as of this 1st day of December, 1997 by and among deCODE genetics, Inc., a
Delaware Corporation having its principal place of business at Xxxxxxxxx 0, 000
Xxxxxxxxx, Xxxxxxx (the "Company"), Vane Associates, a partnership having its
principal place of business at 0 Xxxxx Xxxx, Xxxxxx Xxxx, Xxxxxx, Xxxx XX00XX,
Great Britain (the "Consultant") and Xxx Xxxx Xxxx, having an address of 0 Xxxxx
Xxxx, Xxxxxx Xxxx, Xxxxxx, Xxxx XX00XX, Great Britain.
PRELIMINARY STATEMENTS
A. The Company and the Consultant have entered into that certain
Consultancy Contract (the "Contract") dated as of December 1, 1997 pursuant to
which the Consultant has agreed to provide consulting services to the Company.
B. Section 3.1 of the Contract provides for the payment of certain fees
and the issuance of options to purchase the Company's common stock to the
Consultant as compensation for the Consultant's services.
C. The Company and the Consultant wish to amend Section 3.1 of the
Contract as provided herein.
NOW, THEREFORE, in consideration of the foregoing statements and the
mutual covenants and agreements of the parties contained in this Amendment, the
parties hereto agree as follows:
1. Section 3.1 of the Contract is hereby deleted in its entirety and
replaced with the following paragraphs:
"3.1 In consideration of the Consultant's Services and subject to
approval by the Company's Board of Directors, which shall be
confirmed to Consultant prior to commencement, the Company
shall pay to Vane Associates $2,000 per day for each Board
Meeting that Xxx Xxxx Xxxx ("Xxx Xxxx") attends and shall
issue to Sir John, on the date of this agreement, and on each
of the subsequent three anniversaries of this agreement, an
option to purchase up to 15,000 shares of Common Stock of the
Company (the "Options"), provided that Sir John continues to
serves as a director of the Company at the time the Options
are to be issued.
"3.2 The Options shall be nonstatutory stock options, issued
outside of the Company's 1996 Equity Incentive Plan, and shall
have an exercise price equal to the fair market value of the
Company's Common Stock on each date of grant. The Options
shall vest immediately upon grant thereof.
-1-
8
"3.3 In consideration of the exercise price of the Options, and in
the event that Sir John elects a deferred payment arrangement
as the method of payment Sir John shall (1) deliver payment to
the Company in an amount equal to the par value of the shares
of stock received upon exercise of the Options, and (2)
execute and deliver a nonrecourse promissory note, in form and
substance mutually agreeable to the parties (the "Note") to
the Company as payment for the remainder of the exercise price
of such Options. The Note shall be secured by a pledge to the
Company of the shares purchased upon exercise of the Options,
as evidenced by a pledge agreement to be entered into by the
Company and Sir John, in form and substance mutually agreeable
to the parties (the "Pledge Agreement"). Further, in the case
of any event of default under the Note, the Company's
exclusive remedy under the Note and Pledge Agreement shall be
the return of any shares of stock subject to the Pledge
Agreement having a fair market value equal to the then
outstanding principal balance of the Note, to the Company's
treasury."
2. Section 3.2 of the Contract shall be renumbered as Section 3.
4.
3. Except as specifically provided herein, the Contract shall be
unaffected by this Amendment and shall continue in full force and effect. Unless
otherwise expressly provided herein, the capitalized terms used in this
Amendment without further definition have the meanings ascribed thereto in the
Contract.
*****
-2-
9
IN WITNESS WHEREOF, each of the parties hereto has caused to be
executed by its duly authorized representative this Amendment to Consultancy
Contract as of the date first set forth above.
deCODE genetics, Inc.
By: /s/ Xxxx Xxxxxxxxxx
-------------------
Xxxx Xxxxxxxxxx
President
VANE ASSOCIATES, a partnership
By: /s/ Xxxx Xxxx
----------------
Name: Xxx Xxxx Xxxx
Title:
/s/ Xxxx Xxxx
---------------
Xxx Xxxx Xxxx
-3-
